Skip to main content
OpenTrials
Completed

NCT Number: NCT02687217

Effect of Peri-operative Supplemental Oxygen in Wound Infection After Appendectomy

The study evaluates the role of supplemental hyper-oxygenation given perioperatively on wound site infection after appendectomy. Half of the patients received ≥50% oxygen and half of them received no oxygen during the surgical procedure.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patient with the diagnosis of acute appendicitis of >15 years of age group, with no comorbidities who presented to surgical emergency in Dr. Ram Manohar Lohia Hospital were considered for the present study.

30 patients who fulfilled the inclusion criteria and who voluntarily consented for the study were randomly allocated to the two groups- Group A (control group) and Group B (study group).

These patients were operated through Mc-Burney incision given in the right lower quadrant.

Both the groups were comparable in their demographic and preoperative profile. The study group was given ≥50% of oxygen intraoperatively and the control group was given no oxygen.

In postoperative period, oxygen was given to group A at the rate of 4 litre/minute (L/min) and group B at the rate of 6 litre/minute (L/min).

The assessment of the wound was done by using ASEPSIS (Additional treatment; Serous discharge; Erythema; Purulent exudate; Separation of deep tissues; Isolation of bacteria; and Stay) score. A score of more than 20 is considered to be infected.

Fever, raised total leucocyte count, positive pus culture, Ultrasound evidence of fluid collections, removal of sutures and duration of hospital stay were also measured for the evaluation of economic implications due to SSI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis or Radiological diagnosis of acute appendicitis.
  • Appendectomy through the Mc Burney incision.

Exclusion criteria

  • Patients with chronic obstructive pulmonary diseases.
  • Immunodeficiency disease.
  • Patients requiring midline incision.
  • Patients requiring general anaesthesia after failure of spinal anaesthesia.
  • Patients requiring higher oxygen in perioperative period.

Treatment and study plan

Oxygen

Drug

Hyperoxygenation ≥50% of oxygen by mask(non-rebreathing) was given through out the surgery.

Received 6L/min of oxygen through venturimask upto 2 hours in post operative period.

Hyperoxygenation refers to provision of ≥50% of oxygen by mask(non-rebreathing) through out the surgery.

Primary outcomes

  1. ASEPSIS Score

    Time frame: 14 days

    ASEPSIS score- Additional treatment; Serous discharge; Erythema; Purulent exudate; Separation of deep tissues; Isolation of bacteria; and Stay. A daily score of 20 or more considered evidence of infection.

    Category of infection:

    Total score of 0-10 satisfactory healing; 11-20 disturbance of healing; 21-30 minor wound infection; 31-40 moderate wound infection; > 40 severe wound infection.

Secondary outcomes

  1. Number of Patients Requiring Additional Investigations

    Time frame: 14 days

    Sonography; Pus culture; blood culture; Total Leucocyte Count.

  2. Number of Patients Requiring Additional Treatment

    Time frame: 14 days

    Requirement of antipyretics; increased dose/ duration of antibiotic usage other than standard protocol; need for change to higher antibiotics; requirement of drainage procedures for pus/ wound infections; requirement for additional dressing sessions

Sponsors and collaborators

Lead sponsor

Lady Hardinge Medical College

Other Gov

Registry information

Official study title

Role of Perioperative Hyperoxygenation in Wound Infection Following Surgery for Acute Appendicitis: A Randomised Controlled Trial.

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Feb 22, 2016
Registry last updated
May 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.